Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.095 USD | +7.63% |
|
+15.32% | +15.61% |
07-08 | Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug | MT |
07-01 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 198M | |
+25.04% | 46.56B | |
+45.38% | 41.67B | |
+0.08% | 41.16B | |
+32.72% | 32.4B | |
+20.85% | 28.18B | |
-6.35% | 28.1B | |
+48.86% | 14.52B | |
+47.46% | 13.74B | |
+3.32% | 12.17B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Transcript : Outlook Therapeutics, Inc. - Special Call